does tirzepatide cause low blood pressure and Risk GLP-1 and Low Blood Pressure:

Nutrition-dense, fibre-rich and designed to adapt to your appetite

Retatrutide is an investigational triple-agonist compound in Phase 3 trials

Learn why some patients experience cramping on semaglutide or tirzepatide, the indirect mechanisms involved, and evidence-based strategies to prevent and manage muscle symptoms during GLP-1 therapy.

Trial registration EudraCT number: 2015-005585-32, ClinicalTrials.gov: NCT04122716

Achieving and sustaining a healthy weight requires a personalized and comprehensive approach

Medicaid policies on GLP-1 weight loss medications differ significantly across states, with many requiring prior authorization or limiting coverage to diabetes treatment